{"id":"alacepril","rwe":[{"pmid":"41073682","year":"2025","title":"Risk of liver dysfunction with ACE inhibitors based on real-world data from the MID-NET(®) in Japan.","finding":"","journal":"Hypertension research : official journal of the Japanese Society of Hypertension","studyType":"Clinical Study"},{"pmid":"40459695","year":"2025","title":"Effects of high-dose alacepril on the renin-angiotensin-aldosterone system and autonomic nervous system function in healthy dogs.","finding":"","journal":"Veterinary research communications","studyType":"Clinical Study"},{"pmid":"38612317","year":"2024","title":"Evaluation of Alacepril Administration in Canine Patent Ductus Arteriosus According to Plasma Chymase Activity.","finding":"","journal":"Animals : an open access journal from MDPI","studyType":"Clinical Study"},{"pmid":"34017819","year":"2021","title":"Molecular Docking and Dynamics Simulation Revealed the Potential Inhibitory Activity of ACEIs Against SARS-CoV-2 Targeting the hACE2 Receptor.","finding":"","journal":"Frontiers in chemistry","studyType":"Clinical Study"},{"pmid":"31273801","year":"2019","title":"A new strategy for taste masking on bitter drug by other combined drug in fixed-dose combination: bitterness of Amlodipine besylate could be masked efficiently by Valsartan.","finding":"","journal":"The Journal of pharmacy and pharmacology","studyType":"Clinical Study"}],"tags":[{"label":"Angiotensin Converting Enzyme Inhibitor","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Angiotensin-converting enzyme","category":"target"},{"label":"ACE","category":"gene"},{"label":"Active","category":"status"},{"label":"Essential hypertension","category":"indication"},{"label":"Par Pharm","category":"company"},{"label":"Approved 1980s","category":"decade"},{"label":"Angiotensin-Converting Enzyme Inhibitors","category":"pharmacology"},{"label":"Antihypertensive Agents","category":"pharmacology"},{"label":"Cardiovascular Agents","category":"pharmacology"},{"label":"Enzyme Inhibitors","category":"pharmacology"},{"label":"Protease Inhibitors","category":"pharmacology"}],"phase":"marketed","safety":{"commonSideEffects":[]},"trials":[],"aliases":[],"company":"Par Pharm","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=ALACEPRIL","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:22:04.009431+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:22:09.581873+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=ALACEPRIL","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:22:09.807480+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2103775/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:22:10.516991+00:00"}},"allNames":"cetapril","offLabel":[],"synonyms":["alacepril","cetapril","DU-1219","cenapride"],"timeline":[{"date":"1981-04-06","type":"positive","source":"DrugCentral","milestone":"FDA approval (Par Pharm)"}],"brandName":"Cetapril","ecosystem":[{"indication":"Essential hypertension","otherDrugs":[],"globalPrevalence":1280000000}],"mechanism":{"target":"Angiotensin-converting enzyme","novelty":"Follow-on","targets":[{"gene":"ACE","source":"DrugCentral","target":"Angiotensin-converting enzyme","protein":"Angiotensin-converting enzyme"}],"moaClass":"Angiotensin-converting Enzyme Inhibitors","modality":"Small Molecule","drugClass":"Angiotensin Converting Enzyme Inhibitor","explanation":"","oneSentence":"","technicalDetail":"Cetapril inhibits the angiotensin-converting enzyme (ACE), a peptidyl dipeptidase that catalyzes the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor, thereby reducing peripheral resistance and lowering blood pressure."},"commercial":{"launchDate":"1981","_launchSource":"DrugCentral (FDA 1981-04-06, PAR PHARM)"},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/101","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=ALACEPRIL","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T08:31:18.187910","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:22:12.312683+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"benazepril","drugSlug":"benazepril","fdaApproval":"1991-06-25","genericCount":12,"patentStatus":"Off-patent — generic available","relationship":"same-target"},{"drugName":"captopril","drugSlug":"captopril","fdaApproval":"1981-04-06","genericCount":21,"patentStatus":"Off-patent — generic available","relationship":"same-target"},{"drugName":"edetic acid","drugSlug":"edetic-acid","fdaApproval":"1953-07-16","relationship":"same-target"},{"drugName":"enalapril","drugSlug":"enalapril","fdaApproval":"1985-12-24","patentExpiry":"Nov 6, 2032","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"enalaprilat","drugSlug":"enalaprilat","fdaApproval":"1988-02-09","genericCount":4,"patentStatus":"Off-patent — generic available","relationship":"same-target"},{"drugName":"fosinopril","drugSlug":"fosinopril","fdaApproval":"1991-05-16","genericCount":10,"patentStatus":"Off-patent — generic available","relationship":"same-target"},{"drugName":"lisinopril","drugSlug":"lisinopril","fdaApproval":"1987-12-29","patentExpiry":"Nov 6, 2035","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"losartan","drugSlug":"losartan","fdaApproval":"1995-04-14","patentExpiry":"Oct 7, 2041","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"moexipril","drugSlug":"moexipril","fdaApproval":"1995-04-19","genericCount":4,"patentStatus":"Off-patent — generic available","relationship":"same-target"},{"drugName":"perindopril","drugSlug":"perindopril","fdaApproval":"1993-12-30","genericCount":5,"patentStatus":"Off-patent — generic available","relationship":"same-target"}],"genericName":"alacepril","indications":{"approved":[{"name":"Essential hypertension","source":"DrugCentral","snomedId":59621000,"regulator":"FDA","usPrevalence":119900000,"globalPrevalence":1280000000,"prevalenceMethod":"curated","prevalenceSource":"WHO, 2023"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"benazepril","brandName":"benazepril","genericName":"benazepril","approvalYear":"1991","relationship":"same-target"},{"drugId":"captopril","brandName":"captopril","genericName":"captopril","approvalYear":"1981","relationship":"same-target"},{"drugId":"edetic-acid","brandName":"edetic acid","genericName":"edetic acid","approvalYear":"1953","relationship":"same-target"},{"drugId":"enalapril","brandName":"enalapril","genericName":"enalapril","approvalYear":"1985","relationship":"same-target"},{"drugId":"enalaprilat","brandName":"enalaprilat","genericName":"enalaprilat","approvalYear":"1988","relationship":"same-target"},{"drugId":"fosinopril","brandName":"fosinopril","genericName":"fosinopril","approvalYear":"1991","relationship":"same-target"},{"drugId":"lisinopril","brandName":"lisinopril","genericName":"lisinopril","approvalYear":"1987","relationship":"same-target"},{"drugId":"losartan","brandName":"losartan","genericName":"losartan","approvalYear":"1995","relationship":"same-target"},{"drugId":"moexipril","brandName":"moexipril","genericName":"moexipril","approvalYear":"1995","relationship":"same-target"},{"drugId":"perindopril","brandName":"perindopril","genericName":"perindopril","approvalYear":"1993","relationship":"same-target"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"MMSL":"4347","NDDF":"000656","UNII":"X39TL7JDPF","CHEBI":"CHEBI:31182","VANDF":"4017614","INN_ID":"5458","RXNORM":"1998","UMLSCUI":"C0051050","chemblId":"CHEMBL2103775","ChEMBL_ID":"CHEMBL2103775","KEGG_DRUG":"D01900","DRUGBANK_ID":"DB01197","PUBCHEM_CID":"71992","SNOMEDCT_US":"29439004","MESH_DESCRIPTOR_UI":"D002216","MESH_SUPPLEMENTAL_RECORD_UI":"C046835"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[{"period":"1981-","companyName":"Par Pharm","relationship":"Original Developer"}],"publicationCount":86,"therapeuticAreas":["Cardiovascular"],"biosimilarFilings":[],"originalDeveloper":"Par Pharm","recentPublications":[{"date":"2025 Dec","pmid":"41073682","title":"Risk of liver dysfunction with ACE inhibitors based on real-world data from the MID-NET(®) in Japan.","journal":"Hypertension research : official journal of the Japanese Society of Hypertension"},{"date":"2025 Jun 3","pmid":"40459695","title":"Effects of high-dose alacepril on the renin-angiotensin-aldosterone system and autonomic nervous system function in healthy dogs.","journal":"Veterinary research communications"},{"date":"2024 Apr 2","pmid":"38612317","title":"Evaluation of Alacepril Administration in Canine Patent Ductus Arteriosus According to Plasma Chymase Activity.","journal":"Animals : an open access journal from MDPI"},{"date":"2021","pmid":"34017819","title":"Molecular Docking and Dynamics Simulation Revealed the Potential Inhibitory Activity of ACEIs Against SARS-CoV-2 Targeting the hACE2 Receptor.","journal":"Frontiers in chemistry"},{"date":"2019 Sep","pmid":"31273801","title":"A new strategy for taste masking on bitter drug by other combined drug in fixed-dose combination: bitterness of Amlodipine besylate could be masked efficiently by Valsartan.","journal":"The Journal of pharmacy and pharmacology"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"Par Pharm","companyId":"par-pharm","modality":"Small molecule","firstApprovalDate":"1981","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:22:12.312683+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":false,"score":1}}